Schedule 13D ownership disclosure
Nautilus Biotechnology, Inc.
Common stock, par value $0.0001 per share · CUSIP: 63909J108
Event date: 2026-03-02
- Filing-level shares
- 21,249,965.00
- Percent of class
- 16.3%
- Sujal PatelReported CIK 0001378830
Shares: 21,249,965.00 · Class: 16.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001378830-26-000005
- Form type
- SCHEDULE 13D/A
- Filer
- Nautilus Biotechnology, Inc.
- CIK
- CIK 1808805
- Filed
- Mar 04, 2026
- Reporting period
- Mar 02, 2026
- Description
- Schedule 13D beneficial ownership